A new study by researchers at Dana-Farber Cancer Institute suggests that despite a commitment by many dispensary workers to educate themselves about medical cannabis, dispensaries often prioritize sales skills over cannabis knowledge.
This is the first known human health risk assessment to evaluate the large number of heavy metals that may be present in cannabis flower, concentrates and vape devices.
The company now offers seamless testing services for cannabis across California, Michigan, Oregon, and Colorado, as well as hemp testing capabilities nationwide.
By studying human brain organoids — tissue cultures grown from stem cells that can mimic the developing brain — researchers have found that LSD regulates numerous processes related to neuroplasticity in the human brain.
By demonstrating that ketamine induces only a brief increase in dopamine and does not alter neuronal communication, a team from the University of Geneva suggests that its therapeutic use may be safe.
PSIL-001 and PSIL-002 show promising antidepressant effects without hallucinations while having improved learning and memory tendencies over a psilocybin mimic in a mouse model.
The finding that cannabis legalization could help reduce synthetic cannabinoid exposures through offering a safer alternative is an important new perspective on harm reduction
While cigarette use has been declining for decades in the US, a new study finds that adults who use cannabis daily do not perceive smoking a pack a day as being as harmful as those who do not use cannabis in the US.
Participants in the study endorsed using medical cannabis for menopause-related symptoms including sleep disturbance, mood/anxiety and a mutlitude of other uses.